AGC adds another major Covid-19 vaccine maker to the client list with BioNTech pact for plasmid DNA

With the demand for contract manufacturers at an all-time high amid Covid-19, German firm AGC hasn’t been shy about its open-door policy with major players. Now, the CDMO will work with BioNTech to produce plasmid DNA crucial to its vaccine.